Schrödinger
Venture Capital
Physics-based computational drug discovery company that also takes strategic equity stakes in biotech partners as part of collaboration and licensing deals.
New York, United States · 1+ investments
Biotech
- Headquarters
- New York, United States
- Website
- schrodinger.com
- Total Investment
- 1
- Last Investment
- May 2024
Investment Thesis
Schrödinger, Inc. co-founds and takes equity stakes in biotech partners like Nimbus Therapeutics and Morphic Therapeutic in exchange for access to its computational drug-discovery platform.
Schrödinger is a Venture Capital firm based in New York, United States. It has made 1 investment in Biotech.
Investment History
Sign up to view investment history
Create a free account — 10 credits a month to unlock deal history, amounts, and round details.